Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Stern

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 14, 2026
Anti-amyloid antibody equilibrium binding to Aβ aggregates from human Alzheimer's disease brainKatrine D Bjørnholm, P Monroe Butler, Anna E Francis, et al.
Metabolites|June 23, 2022
A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting StrategiesDaniel E Lefever, Mark T Miedel, Fen Pei, et al.
Blood|October 24, 2002
Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopeniaDietmar Seiffert, Andrew M Stern, William Ebling, et al.
Scientific Reports|December 21, 2017
Connecting Neuronal Cell Protective Pathways and Drug Combinations in a Huntington's Disease Model through the Application of Quantitative Systems PharmacologyFen Pei, Hongchun Li, Mark J Henderson, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision TherapyMengying Xia, Maboubeh Varmazyad, Iris Pla Palacin, et al.
Frontiers in Cell and Developmental Biology|September 26, 2024
Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapyMengying Xia, Mahboubeh Varmazyad, Iris Pla-Palacín, et al.
Cancer Cell|September 13, 2011
Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABLRaghuveer Singh Mali, Baskar Ramdas, Peilin Ma, et al.
Blood|May 3, 2002
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediatedJeffrey T Billheimer, Ira B Dicker, Richard Wynn, et al.
Neuron|May 1, 2025
CLU alleviates Alzheimer's disease-relevant processes by modulating astrocyte reactivity and microglia-dependent synaptic densityAlexandra M Lish, Elyssa F L Grogan, Courtney R Benoit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2015
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer PatientsPeilu Wang, Amir Bahreini, Rekha Gyanchandani, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 14, 2026
Anti-amyloid antibody equilibrium binding to Aβ aggregates from human Alzheimer's disease brainKatrine D Bjørnholm, P Monroe Butler, Anna E Francis, et al.
Metabolites|June 23, 2022
A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting StrategiesDaniel E Lefever, Mark T Miedel, Fen Pei, et al.
Blood|October 24, 2002
Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopeniaDietmar Seiffert, Andrew M Stern, William Ebling, et al.
Scientific Reports|December 21, 2017
Connecting Neuronal Cell Protective Pathways and Drug Combinations in a Huntington's Disease Model through the Application of Quantitative Systems PharmacologyFen Pei, Hongchun Li, Mark J Henderson, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision TherapyMengying Xia, Maboubeh Varmazyad, Iris Pla Palacin, et al.
Frontiers in Cell and Developmental Biology|September 26, 2024
Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapyMengying Xia, Mahboubeh Varmazyad, Iris Pla-Palacín, et al.
Cancer Cell|September 13, 2011
Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABLRaghuveer Singh Mali, Baskar Ramdas, Peilin Ma, et al.
Blood|May 3, 2002
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediatedJeffrey T Billheimer, Ira B Dicker, Richard Wynn, et al.
Neuron|May 1, 2025
CLU alleviates Alzheimer's disease-relevant processes by modulating astrocyte reactivity and microglia-dependent synaptic densityAlexandra M Lish, Elyssa F L Grogan, Courtney R Benoit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2015
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer PatientsPeilu Wang, Amir Bahreini, Rekha Gyanchandani, et al.
Pageof 9